Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2003

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

patent: 2 patents

Citations

dimensions_citation: 44 Dimensions

Readers on

mendeley: 32 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

Individual 5-fluorouracile dose optimization in folfiri treatment

Grant US-9463193-B2

United States of America

Individual 5-fluorouracile dose optimization in FOLFOX treatment

Grant AU-2008362108-B2

Australia